United Therapeutics Corporation (NASDAQ:UTHR) Q1 2026 Earnings Call Transcript May 6, 2026
United Therapeutics Corporation misses on earnings expectations. Reported EPS is $5.82 EPS, expectations were $7.
Operator: Good morning, and welcome to the United Therapeutics Corporation First Quarter 2026 Corporate Update. My name is JL, and I will be your operator today. [Operator Instructions] Please note that this call is being recorded. I’ll now turn the webcast over to Harry Silvers, Investor...
